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In 2004, the German public health institute, the Robert 
Koch Institute (RKI), prioritised pathogens by public 
health criteria and presented the methodology and 
findings. In order to further improve the methodology, 
the RKI invited experts to give feedback on this via a 
structured web-based questionnaire. The survey was 
completed by 72 participants during 15 July 2008 to 15 
January 2009. Prioritisation of pathogens was consid-
ered as useful for public health purposes by 68 partic-
ipants and for both surveillance and epidemiological 
research by 64 participants. Additional pathogens 
were suggested, including some that are resistant to 
antimicrobials. The criteria incidence, severity, out-
break potential, emerging potential and preventability 
were each considered as useful or very useful for the 
prioritisation (by more than 65 participants for each 
criterion). Weighting of the criteria was judged as rel-
evant or very relevant by 67 of participants, but needs 
more explanation. It was also suggested that the 
group carrying out the prioritisation be composed of 
a median of 15 experts (range: 5–1,000). The feedback 
obtained in the survey has been taken into account in 
the modification of the methodology for the next round 
of prioritisation, which started in December 2010.
Background 
Strengthening communicable disease surveillance and 
response at national level requires a substantial and 
long-term commitment of human, financial and mate-
rial resources. The usefulness of prioritisation as part 
of this process, irrespective of the methodology used, 
has been demonstrated by several research groups 
[1-7]. This investment begins ideally with a system-
atic review of the national priorities for surveillance 
[8,9]. In 2004, the Department for Infectious Disease 
Epidemiology of the Robert Koch Institute (RKI), the 
German national public health institute in the portfo-
lio of the federal Ministry of Health, initiated an exer-
cise on prioritising various pathogens to guide the 
research and surveillance strategies of the depart-
ment. After a literature review, we developed a meth-
odology, including a scoring system for 12 criteria for 
selected pathogens. For each criterion, a three-tiered 
score (–1, 0 and +1) was used. Independently, each cri-
terion was weighted: a group of experts ranked the 12 
criteria in terms of perceived importance. A mean value 
was calculated for each criterion (its weight), by which 
the score of the criteria was to be multiplied. The total 
weighted scores led to a ranked list of 85 pathogens. 
Initial findings were presented at three international 
scientific conferences in 2006 and 2007 [10-12] and 
were covered in a national non-scientific magazine [13]: 
this generated public interest and feedback from scien-
tists and patient advocacy groups. 
A review of previous prioritisations strategies used by 
others and details of the methodological approach we 
used (Figure) were subsequently published in 2008 
[14-16]. A review and possible revision of our approach 
is part of the methodology. This current process is 
described in this paper.
To refine the prioritisation methodology further, 
develop it into a standard tool and ensure that it is 
fully understandable, an open call was issued, inviting 
respondents to complete an online structured ques-
tionnaire on the prioritisation methodology and rele-
vance of the prioritisation tool. In addition, we targeted 
representatives of the scientific community as well as 
health policy stakeholders.
This paper presents the findings of the survey and dis-
cusses their potential implications for the planned mod-
ification of the methodology of prioritising pathogens.
Survey approach
When we published extensive descriptions of the pri-
oritisation methodology [14-16], we invited readers 
to give feedback and comments through an online 
questionnaire. Additionally, we contacted by email 
all German regional epidemiologists (n=60), all mem-
bers and alternates of the scientific Advisory Forum 
(n=64) of the European Centre for Disease Prevention 
and Control (ECDC), all heads of the German national 
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reference laboratories (n=66) and all members of the 
Committee for Epidemiology of Infections (n=12) and 
four relevant German epidemiological societies and 
associations, asking them to take part in the online 
survey. 
The online survey contained the list of the 85 selected 
pathogens and the 12 criteria used in the prioritisation, 
with questions on the usefulness and appropriateness 
of these criteria. In order to compare the participants’ 
feedback on the criteria, we gave a numerical value to 
each possible answer and calculated the mean value for 
each criterion. To assess the usefulness of the criteria, 
the possible answers were: very useful (with a value of 
3), useful (value of 2) and dispensable (value of 1). 
The survey contained additional questions on the 
number and profession of experts that participants 
considered should take part in a prioritisation process 
and also questions about the participants themselves. 
The questionnaire was internally pretested and then 
posted in both English and German on the RKI home 
page from 15 July 2008 to 15 January 2009. The data 
were analysed using Epi Info software. 
Survey findings
Participants
In total, 72 participants completed the survey. Most 
(n=35) found out about the it from the national epide-
miological bulletin, 18 received the email request sent 
by the RKI, 11 read about it in Eurosurveillance [15] and 
eight found it coincidentally on the Internet. 
Of the 72 experts, 54 were working in Germany, nine 
in other European Union (EU) countries and six in non-
EU countries. For three respondents, no information on 
the country in which they worked was available. 
The participants had a variety of professions and insti-
tutional affiliations, with the majority being medical 
doctors by training (Table 1).
Almost all participants (n=68) provided information on 
the length of their work experience: the median dura-
tion was 18 years (range: 3–40 years).
Feedback and comments
Prioritising pathogens was considered useful for pub-
lic health purposes by 68 participants, for both sur-
veillance and epidemiological research by 64, and for 
clinical research by 57. Most respondents considered 
prioritisation to be beneficial for public health serv-
ices, at the national (n=58) and international (n=49) 
level. Additionally, 33 participants believed that the 
prioritisation will also be useful for regional public 
health services, universities and ministries of health, 
to guide surveillance and research agendas. A total of 
29 participants considered that it would be beneficial 
to local public health services.
Most participants (n=40) considered that the list of 85 
pathogens [15] was comprehensive and appropriate, 
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while16 proposed changes to the list; 16 answered that 
they did not know. The following additional pathogens 
and topics were suggested: 
•	 all	Brucella spp. 
•	 all	Campylobacter spp. 
•	 Clostridium difficile 






•	 Candida spp. 
•	 Cryptococcus spp. 
•	 Aspergillus spp. 
•	 Fusarium spp. 
•	 human	herpesvirus	(HHV)-6	and	HHV-8	
•	 poxviruses	
•	 Pseudomonas ssp. 
•	 Rickettsia spp. 
•	 respiratory	syncytial	virus	
•	 Staphylococcus epidermidis 
•	 vectors.	
Seven participants suggested including pathogens 
resistant to antimicrobials as a separate group (e.g. 
bacteria producing extended-spectrum beta-lacta-
mase, vancomycin-resistant enterococci and oxacillin-
resistant S. aureus). 
Prioritisation criteria 
Definitions of the scores for each criterion are described 
elsewhere [15]. Table 2 describes the respondents’ rat-
ing of the usefulness of the prioritisation criteria, by 
their profession or institutional affiliation.
Incidence 
Incidence was judged by 68 participants as a very use-
ful or useful criterion for prioritisation. The comments 
received mainly reflected the difficulty in getting 
adequate data on incidence, especially for diseases 
that are not notifiable. One suggestion was to include 
‘unknown’ in the highest score of the criterion, to indi-
cate that the level of attention should be high if infor-
mation is lacking. 
Severity 
This criterion was considered to be useful or very useful 
by 68 participants. Comments referred to the difficulty 
of incorporating different issues such as hospitalisa-
tion, work-time lost due to sick leave and persisting 
disabilities into one single criterion. Furthermore, the 
issue was raised of how work-time lost due to sick leave 
can be judged if children, unemployed and retired peo-
ple are concerned. It was also suggested that cost of 
medical care be included as an additional aspect.
Mortality 
A total of 62 participants thought this a useful or very 
useful criterion. One respondent suggested that life-
years lost be used instead of mortality for diseases 
that affect children more than adults. The scarcity of 
reliable data sources to score this criterion was a con-
cern expressed by three of the participants. 
As replacing the mortality criterion with case fatality 
rate had already been suggested in the prioritisation 
process in 2004 – as mortality is influenced by inci-
dence (a separate criterion) – we asked in our survey 
whether case fatality rate should be used instead. A 
total of 33 participants recommended the replacement, 
17 preferred mortality, while nine could not see a differ-
ence and 13 did not have an opinion. Five participants 
were in favour of including both criteria.
Outbreak potential 
This criterion was considered by 69 participants as 
useful or very useful. Two participants suggested using 
the basic reproductive rate (R0) of a pathogen, rather 
than the frequency of outbreaks, to judge outbreak 
potential. A fixed threshold of five or more cases per 
outbreak for all pathogens was questioned by three 
participants. 
Trend 
A total of 57 participants considered this as a useful or 
very useful criterion. However, for 12 respondents the 
definitions used for each score were not clear enough. 
They suggested that a timescale for the trend should 
be determined. Questions were also raised on how to 
score diseases with unclear trends.
Table 1
Employment information and education level of 
prioritisation survey participants, Robert Koch Institute, 
15 July 2008 to 15 January 2009 (n=72)
Employment information and education level Number of respondents 
Profession or institutional affiliation
Local public health service 11
National public health service 10 
Regional public health service 8 
Infectious disease research facility 8
Microbiologist 6





Degree in medicine 45
Doctoral degree (other than in medicine) 13
Degree in teaching 9
Degree in nursing 4
Masters degree in public health 4
















































































































































































































































































































































































































































































































































































































































































This criterion was judged by 65 of the participants as 
useful or very useful. Five considered that endemicity 
and a low probability of the disease being introduced 
should not be included in the same score. Additionally, 
inclusion of the emergence of pathogen strains resist-
ant to antimicrobials as a separate aspect of the defi-
nition of the highest score was proposed. It was also 
suggested that this criterion should be combined with 
the trend criterion.
Evidence for risk factors/groups 
A total of 62 respondents judged this criterion as use-
ful or very useful. A clear definition of the kind and 
quality of ‘scientific evidence’ was requested by some 
participants. It was also suggested that this criterion 
be combined with the evidence for pathogenesis crite-
rion, to cover transmission routes and pathogenesis. 
Two respondents questioned whether existing sci-
entific evidence should be part of the prioritisation 
approach, as it leads to conflation of the relevance of 
a disease for public health and knowledge of the dis-
ease. These two aspects are important, but should be 
judged independently.
Validity of epidemiologic information 
This criterion was judged by 62 participants as useful 
or very useful. Here the definition of the score 0 (‘epi-
demiologic information exists but is scientifically not 
very valid’) was considered imprecise. The applicability 
of this criterion and the lack of reliable data that are 
needed to score it were raised as concerns.
International duties and public attention 
A total of 52 participants thought this a useful or 
very useful criterion. However, the definitions were 
not clear and as several aspects are included in each 
definition, some participants indicated that it is prob-
lematic to assign a single score in situations when sep-
arate aspects should be scored differently. They also 
thought it hard for the scoring to take into account rap-
idly occurring changes in public or political attention.
Evidence for pathogenesis 
This criterion was considered by 57 of the participants 
as useful or very useful. The problem of assessing 
different aspects of the criterion using a single score 
was raised again. Combination of this criterion with 
the evidence on risk factors/groups criterion was 
suggested.
Preventability 
In total, 67 respondents judged this as a very useful or 
useful criterion. The task of scoring the availability of 
prevention measures and need for further research in 
a single criterion was criticised. It was also suggested 
that availability of an effective vaccine be included as 
a separate criterion. 
Treatability 
This criterion was deemed by 61 respondents as useful 
or very useful. The distinction between the definitions 
of the three scores was not clear to some participants 
and might need clarification. The issue of incorporat-
ing drug resistance into the prioritisation was raised 
again. One participant suggested merging preventabil-
ity, treatability and severity into a single criterion. 
Suggestions for additional criteria
Participants suggested that the prioritisation tool 
include assessment of the economic impact of a dis-
ease or its control measures, the concept of life-years 
saved or lost, emergence of antimicrobial resistance 
and monitoring of vaccination effects, for example, on 
incidence or pathogenicity.
Scoring system
A total of 54 participants found the three-tiered scoring 
system to be adequate; six would have preferred a two-
tiered and four a five-tiered system. Five suggested 
introducing a more continuous scoring (e.g. from low 
to high, on a scale from 1 to 10), whenever possible.
Weighting process
The weighting process was judged by 49 participants 
as very relevant and by 18 as relevant. Two thought 
it irrelevant and three did not know. The weighting 
method was considered plausible but initially difficult 
to understand by 31 participants, 19 understood the 
weighting method immediately and for 13 it remained 
unclear. Some respondents supported the separation 
of the weighting from the actual prioritisation. 
One participant pointed out that basing the numerical 
value of the weighting on the ranking of the criteria 
may result in bias, as it assumes that the difference 
in importance between each criterion in the ranked 
list is always equal. We therefore suggest that values 
between 1 and 10 be used instead for the weighting, 
without any ranking. 
The need for a better description of the weighting proc-
ess was highlighted by two participants.
Size and composition of an expert 
group for prioritisation
The participants proposed that the median size of an 
expert group needed to conduct the prioritisation exer-
cise of surveillance and research activities of a national 
public health agency was 15 (range: 5–1,000). They 
suggested that experts representing the following pro-
fessions or institutions should take part in future exer-
cise rounds: national public health service (suggested 
by 65 participants), university faculty of infectious dis-
eases (by 59), microbiologist (by 57), hospital epidemi-
ologist or hygienist (by 51), international public health 
organisations (by 48), regional public health service 
(by 47), hospital physician (by 45) and local public 
health service (by 37). Two respondents suggested that 
health economists be involved.
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Conclusions
Setting priorities in research can serve as a catalyst 
for public debate and create networks of stakehold-
ers [4,17]. The opinion of the user of the prioritisa-
tion is very important, as exchanging experiences and 
discussing the topics with the various stakeholders 
is highly relevant [3,18]. Indeed, Lomas et al. stated, 
when describing prioritisation efforts, ’The process is 
more important than the science’ [19]. Our survey was 
one step in involving various stakeholders and proved 
very useful in helping to develop our prioritisation 
methodology further, even if the set up of the survey 
was neither able nor intended to be representative. As 
the survey was announced in an open call and as some 
email requests were sent to generic email addresses, 
we have no information about the denominator and are 
therefore unable to calculate the response rate. Given 
the survey design, it is also impossible to tell whether 
the opinions of those who responded were representa-
tive. It is possible that those who chose to take part 
in the survey were those who were relatively positive 
about the prioritisation process. However, even if that 
were the case, they provided constructive criticism 
and comments, which have helped us to improve our 
methodology. 
Overall, the participants commented positively on 
the prioritisation methodology: although there was 
variation between the responses of participants with 
different professions and institutional affiliations, 
the proposed criteria were mostly considered useful. 
However, it became clear that the definitions of some 
criteria were unclear for scoring purposes. We will 
therefore try to clarify the problematic definitions.
Which pathogens should be included?
The suggested list of 85 pathogens was seen as fairly 
comprehensive by most participants. However, given 
the recommendations, we realised that some addi-
tional pathogens could be included in future, as their 
importance has changed since the list was drawn up 
in 2004.
How should the prioritisation take into account 
antimicrobial resistance and emerging diseases?
Interestingly, antimicrobial resistance was mentioned 
at various points in the survey as an essential issue 
that should be addressed. We believe it can be suffi-
ciently accounted for if it is an integral part of the crite-
rion of treatability and we therefore propose that it be 
included in its definition.
Participants also questioned how an endemic disease 
could be scored in the same way as a disease that is 
unlikely to emerge. We believe this to be justified, as 
an endemic disease has generally already led to an 
established infrastructure for prevention, surveillance, 
diagnosis and treatment. Similarly, diseases that are 
not endemic and are very unlikely to emerge in a coun-
try in near future should probably not be considered 
a priority when resources are limited. A disease with 
potential to emerge generates new challenges and 
thus deserves special attention, at least for prevention 
and surveillance. 
How should disease severity be assessed?
One of the issues raised in various ways throughout 
the survey was the challenge of adequately accounting 
for the severity of an illness resulting from an infec-
tious disease. Participants suggested that the pri-
oritisation should take into account other aspects of 
disease severity, such as the economic impact of an ill-
ness, life-years lost, the effect of work-time lost due to 
sick leave if children, unemployed and retired people 
are concerned, and the cost of care. However, including 
the requirement for such detailed information might 
increase the problem of lack of relevant data, result-
ing in difficulty in scoring this criterion, as discussed 
above. Our original approach intentionally attempted 
to keep the score definitions within each criterion as 
simple as possible. We will, however, take those issues 
into consideration when redefining these definitions. 
Detailed instructions concerning the process of 
assigning a single score to a multicategory crite-
rion will be developed and provided during the next 
prioritisation. 
How should the prioritisation take 
into account variability of incidence 
trends and outbreak potential?
Some participants drew attention to the fact that a 
time frame would be needed for the scoring of some 
criteria (e.g. trend or emerging potential). We consider 
that it would depend on how frequent the prioritisation 
exercise is planned to be repeated and what its main 
objective is. For example, a disease with a highly vari-
able incidence from one year to another should prob-
ably have a high score for outbreak potential, while 
the scoring for incidence should probably be based 
on some sort of average yearly figure for the previous 
five or 10 years. Furthermore, if recent observations 
indicate that despite observed fluctuations yearly inci-
dence tends to increase, it should be appropriately 
accounted for in the trend criterion. 
The fixed threshold of five cases or more per outbreak 
for all pathogens was questioned by some partici-
pants. The underlying rational for the threshold was 
that in Germany, only a few households have five or 
more members, suggesting that most outbreaks of less 
than five cases are likely to be limited to one house-
hold. Such outbreaks have fewer implications for pub-
lic health services, as opposed to larger outbreaks. 
Obviously this distinction may be more appropriate for 
common gastrointestinal pathogens, which are respon-
sible for the vast majority of all outbreaks. However, 
for practical reasons we decided to use this threshold 
for all diseases.
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How should criteria be weighted? 
To take into account the fact that not all criteria are simi-
larly important for prioritisation, we included a weighting 
of the criteria, which is independent of the prioritisation. 
The survey participants commented in general that the 
weighting of the criteria is relevant, but that it needs to 
be explained more clearly. Given these comments, we 
will also consider using a discrete scale for the weight-
ing, rather than basing the weighting on ranking.
How can the prioritisation process 
deal with lack of reliable data?
The lack of reliable data – data that are needed to 
score the criteria for each pathogen – was a con-
cern expressed at various points during the survey. 
It was suggested that the evidence level be specified 
for each score. We fear, however, that the complex-
ity and effort required would not be in proportion to 
the expected improvement. Besides, the prioritisa-
tion process was designed to use a Delphi approach 
[20,21], using opinions of senior experts in the field 
rather than a meta-analysis. The current prioritisation 
process already assesses the strength of evidence 
and information available. However, the scores of 
those criteria are simply included in the overall sum 
for each pathogen. One possible amendment of the 
existing methodology would be separate computation 
of ‘knowledge’ criteria, such as evidence or validity, 
and ‘relevance’ criteria, such as incidence, severity or 
treatability. 
A standardised tool for prioritising pathogens will obvi-
ously never be completely perfect and will also never 
please every stakeholder [22,23]. However, it helps to 
improve strategic research planning [5]. We have used 
the findings of this survey to pragmatically improve 
the prioritisation methodology, including clarification 
of the approach, as transparency and understanding 
are essential components of any prioritisation process. 
The next round of the prioritisation exercise, which 
started in December 2010, and which follows the same 
workflow as shown in the Figure is still ongoing: the 
revised methodology and the results will be published 
once the prioritisation is completed. 
The reason for involving multiple stakeholders in the 
improvement process was to ensure a certain level of 
acceptance and agreement on the pathogen prioritisa-
tion list – this list will be a final product of the exercise 
and will inevitably be a sensitive issue that generates 
debate. In addition, any part of the findings and meth-
odology may be used by other institutions to conduct 
their own prioritisation of activities.
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